Stockreport

ANI Pharmaceuticals Q4 2025: Strong Growth, But Execution Risks Emerge [Seeking Alpha]

ANI Pharmaceuticals, Inc.  (ANIP) 
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am Check Earnings Report
PDF I see near-term risks from seasonally weaker Cortrophin sales due to insurance reverifications and delayed impact from the expanded gout sales force. Management reaff [Read more]